ES2147163B1 - Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. - Google Patents

Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.

Info

Publication number
ES2147163B1
ES2147163B1 ES009900182A ES9900182A ES2147163B1 ES 2147163 B1 ES2147163 B1 ES 2147163B1 ES 009900182 A ES009900182 A ES 009900182A ES 9900182 A ES9900182 A ES 9900182A ES 2147163 B1 ES2147163 B1 ES 2147163B1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
expression
adhesion molecules
regulatory activity
soluble extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009900182A
Other languages
English (en)
Other versions
ES2147163A1 (es
Inventor
Almagro Eliseo Quintanilla
Alperi Joaquin Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Especialidades Farmaceuticas Centrum SA
Original Assignee
Especialidades Farmaceuticas Centrum SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Especialidades Farmaceuticas Centrum SA filed Critical Especialidades Farmaceuticas Centrum SA
Priority to ES009900182A priority Critical patent/ES2147163B1/es
Priority to EP00901148A priority patent/EP1172111A1/en
Priority to US09/889,846 priority patent/US6706293B1/en
Priority to PCT/ES2000/000026 priority patent/WO2000043023A1/es
Priority to JP2000594476A priority patent/JP2002535281A/ja
Publication of ES2147163A1 publication Critical patent/ES2147163A1/es
Application granted granted Critical
Publication of ES2147163B1 publication Critical patent/ES2147163B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición farmacéutica con actividad reguladora de la expresión de las moléculas de adhesión y poblaciones linfocitarias y su aplicación como agente antiinflamatorio.Esta composición farmacéutica contiene como principio activo el Anapsos, un extracto hidrosoluble y un extracto liposoluble de los rizomas de Polypodium, junto con excipientes aceptables.
ES009900182A 1999-01-25 1999-01-25 Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. Expired - Fee Related ES2147163B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES009900182A ES2147163B1 (es) 1999-01-25 1999-01-25 Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.
EP00901148A EP1172111A1 (en) 1999-01-25 2000-01-21 Pharmaceutical composition with adhesion molecule expression regulating activity
US09/889,846 US6706293B1 (en) 1999-01-25 2000-01-21 Pharmaceutical composition capable of regulating the expression of adhesion molecules
PCT/ES2000/000026 WO2000043023A1 (es) 1999-01-25 2000-01-21 Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion
JP2000594476A JP2002535281A (ja) 1999-01-25 2000-01-21 接着分子の発現を調節することができる薬剤組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009900182A ES2147163B1 (es) 1999-01-25 1999-01-25 Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.

Publications (2)

Publication Number Publication Date
ES2147163A1 ES2147163A1 (es) 2000-08-16
ES2147163B1 true ES2147163B1 (es) 2001-03-01

Family

ID=8307118

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009900182A Expired - Fee Related ES2147163B1 (es) 1999-01-25 1999-01-25 Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.

Country Status (5)

Country Link
US (1) US6706293B1 (es)
EP (1) EP1172111A1 (es)
JP (1) JP2002535281A (es)
ES (1) ES2147163B1 (es)
WO (1) WO2000043023A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876032B1 (fr) * 2004-10-05 2008-10-31 Greentech Sa Sa Utilisation d'extraits de fougeres dans des preparations cosmetiques ou dermatologiques
CN100431581C (zh) * 2006-01-20 2008-11-12 丽珠医药集团股份有限公司 治疗禽流感的中药组合物、制备方法及其用途
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
DE69527742T2 (de) * 1994-05-06 2002-12-05 Especialidades Farmaceuticas Centrum, S.A. Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten.
AU4152297A (en) * 1996-08-21 1998-03-06 American Home Products Corporation Beta2 integrin cell adhesion molecule inhibitors

Also Published As

Publication number Publication date
US6706293B1 (en) 2004-03-16
WO2000043023A1 (es) 2000-07-27
JP2002535281A (ja) 2002-10-22
ES2147163A1 (es) 2000-08-16
EP1172111A1 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
DK0991407T3 (da) Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer
ES2147163B1 (es) Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
DK1030670T3 (da) Anvendelse af vitamin D-derivater til forstærkning af virkningen af cytotoksiske midler
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
PA8435001A1 (es) Derivados 6,6-heterobiciclicos sustituidos.
DK0762896T3 (da) Tocopherol-sammensætninger til levering af biologisk aktive stoffer
GT199800136A (es) Formas de dosificacion farmaceuticas solidas.
ME00298B (me) Farmaceutski preparat
ATE509616T1 (de) Topische pharmazeutische und/oder cosmetische dosierungssysteme
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
AR032293A1 (es) Estuche farmaceutico
DE69710065D1 (de) Androsten-derivate
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
NO993066L (no) Ny behandling for leddinflammasjon
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
AR025060A1 (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa
PT1150704E (pt) Melagatran para o tratamento da inflamacao
ES2172558T3 (es) Lubricante compatible con radiaciones para dispositivos medicos.
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
ES2191426T3 (es) Composiciones estables que comprenden levosimendano y acido alginico.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000816

Kind code of ref document: A1

Effective date: 20000816

FD1A Patent lapsed

Effective date: 20101018